Antithrombotic Therapy and Freedom From Bridging Stent Occlusion After BEVAR: Multicentre Study Initiated by PRINCE2SS

Objective: Although significant improvement in the success rate and durability of branched endovascular aortic repair (BEVAR) was recently reported, the risk of bridging stent occlusion remains relevant.1,2 The PRINCE2SS international consensus suggests a lifelong antithrombotic therapy, depending on target vessels ’ anatomical characteristics, the use of multiple stents, and the stent’s length.3 In this multicentre international study, the aim was to analyse the risk of bridging stent occlusion after elective BEVAR depending on the antithrombotic therapy and compare it with the PRINCE2SS recommendation.

Source: European Journal of Vascular and Endovascular Surgery - March 1, 2024 Category: Surgery Authors: Vaiva Dabravolskaite, Lorenz Meuli, Ozan Yazar, Lee Bouwmann, Hozan Mufty, Geert Maleux, Pekka Aho, Harri Hakovirta, Maarit Venermo, Vladimir Makaloski Source Type: research